HCWB · ISSUER CIK 1828673
HCW Biologics Inc.
Between Jul 31, 2026 and Oct 28, 2026, 3 HCW Biologics Inc. insiders reported $100K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Wong Hing C (Chief Executive Officer, Director, 10% Owner), with $60K.
↗3 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$100KInsider buying
$0.00Insider selling
+$100KNet open-market
Jul 31, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 202616:10 | Jul 29, 2026 | HCWB | Chief Executive Officer, Director, 10% Owner | P · Buy | $2.59 | +23,210 | 125,845 | +23% | +$60K | -85.1% | -52.8% |
| Jul 31, 202616:06 | Jul 29, 2026 | HCWB | SVP of Business Development | P · Buy | $2.59 | +7,736 | 8,691 | +810% | +$20K | -85.1% | -52.8% |
| Jul 31, 202616:02 | Jul 29, 2026 | HCWB | Director | P · Buy | $2.59 | +7,736 | 41,644 | +23% | +$20K | -85.1% | -52.8% |